vs
ALLIANCE ENTERTAINMENT HOLDING CORP（AENT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ALLIANCE ENTERTAINMENT HOLDING CORP的1.7倍（$622.0M vs $368.7M），Royalty Pharma plc净利率更高（34.4% vs 2.5%，领先31.9%），Royalty Pharma plc同比增速更快（4.8% vs -6.3%），过去两年ALLIANCE ENTERTAINMENT HOLDING CORP的营收复合增速更高（32.1% vs 4.6%）
该企业是一家总部位于加拿大多伦多的传媒公司，核心业务为加拿大市场提供专业特色媒体服务，除多伦多总部外，还在哈利法克斯、洛杉矶、伦敦、都柏林、马德里、巴塞罗那、香农以及悉尼多地设有办事机构。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AENT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.7倍
$368.7M
营收增速更快
RPRX
高出11.1%
-6.3%
净利率更高
RPRX
高出31.9%
2.5%
两年增速更快
AENT
近两年复合增速
4.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $368.7M | $622.0M |
| 净利润 | $9.4M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 4.7% | 62.4% |
| 净利率 | 2.5% | 34.4% |
| 营收同比 | -6.3% | 4.8% |
| 净利润同比 | 32.8% | 2.9% |
| 每股收益（稀释后） | $0.18 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AENTRPRX
| Q4 25 | $368.7M | $622.0M | ||
| Q3 25 | $254.0M | $609.3M | ||
| Q2 25 | $227.8M | $578.7M | ||
| Q1 25 | $213.0M | $568.2M | ||
| Q4 24 | $393.7M | $593.6M | ||
| Q3 24 | $229.0M | $564.7M | ||
| Q2 24 | $236.9M | $537.3M | ||
| Q1 24 | $211.2M | $568.0M |
净利润AENTRPRX
| Q4 25 | $9.4M | $214.2M | ||
| Q3 25 | $4.9M | $288.2M | ||
| Q2 25 | $5.8M | $30.2M | ||
| Q1 25 | $1.9M | $238.3M | ||
| Q4 24 | $7.1M | $208.2M | ||
| Q3 24 | $397.0K | $544.0M | ||
| Q2 24 | $2.5M | $102.0M | ||
| Q1 24 | $-3.4M | $4.8M |
营业利润率AENTRPRX
| Q4 25 | 4.7% | 62.4% | ||
| Q3 25 | 4.2% | 70.1% | ||
| Q2 25 | 4.3% | 36.3% | ||
| Q1 25 | 1.7% | 94.0% | ||
| Q4 24 | 3.8% | 60.9% | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.2% | 50.2% | ||
| Q1 24 | -0.3% | -13.0% |
净利率AENTRPRX
| Q4 25 | 2.5% | 34.4% | ||
| Q3 25 | 1.9% | 47.3% | ||
| Q2 25 | 2.5% | 5.2% | ||
| Q1 25 | 0.9% | 41.9% | ||
| Q4 24 | 1.8% | 35.1% | ||
| Q3 24 | 0.2% | 96.3% | ||
| Q2 24 | 1.1% | 19.0% | ||
| Q1 24 | -1.6% | 0.8% |
每股收益（稀释后）AENTRPRX
| Q4 25 | $0.18 | $0.49 | ||
| Q3 25 | $0.10 | $0.67 | ||
| Q2 25 | $0.11 | $0.07 | ||
| Q1 25 | $0.04 | $0.55 | ||
| Q4 24 | $0.14 | $0.46 | ||
| Q3 24 | $0.01 | $1.21 | ||
| Q2 24 | $0.05 | $0.23 | ||
| Q1 24 | $-0.07 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $117.6M | $9.7B |
| 总资产 | $434.1M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AENTRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | $4.3M | $950.1M | ||
| Q2 24 | $1.1M | $1.8B | ||
| Q1 24 | $1.6M | $843.0M |
总债务AENTRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益AENTRPRX
| Q4 25 | $117.6M | $9.7B | ||
| Q3 25 | $108.1M | $9.6B | ||
| Q2 25 | $103.2M | $9.5B | ||
| Q1 25 | $97.4M | $9.8B | ||
| Q4 24 | $95.6M | $10.3B | ||
| Q3 24 | $88.0M | $10.3B | ||
| Q2 24 | $87.6M | $9.8B | ||
| Q1 24 | $85.1M | $9.9B |
总资产AENTRPRX
| Q4 25 | $434.1M | $19.6B | ||
| Q3 25 | $383.0M | $19.3B | ||
| Q2 25 | $361.2M | $18.3B | ||
| Q1 25 | $349.4M | $17.6B | ||
| Q4 24 | $401.7M | $18.2B | ||
| Q3 24 | $395.7M | $18.0B | ||
| Q2 24 | $340.8M | $17.7B | ||
| Q1 24 | $324.0M | $16.1B |
负债/权益比AENTRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-16.9M | — |
| 自由现金流率自由现金流/营收 | -4.6% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | -1.76× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-1.4M | — |
8季度趋势，按日历期对齐
经营现金流AENTRPRX
| Q4 25 | $-16.5M | $827.1M | ||
| Q3 25 | $2.7M | $702.6M | ||
| Q2 25 | $10.7M | $364.0M | ||
| Q1 25 | $2.5M | $596.1M | ||
| Q4 24 | $25.3M | $742.5M | ||
| Q3 24 | $-11.6M | $703.6M | ||
| Q2 24 | $9.7M | $658.2M | ||
| Q1 24 | $20.0M | $664.6M |
自由现金流AENTRPRX
| Q4 25 | $-16.9M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-11.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $20.0M | — |
自由现金流率AENTRPRX
| Q4 25 | -4.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 9.4% | — |
资本支出强度AENTRPRX
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.0% | — |
现金转化率AENTRPRX
| Q4 25 | -1.76× | 3.86× | ||
| Q3 25 | 0.56× | 2.44× | ||
| Q2 25 | 1.86× | 12.06× | ||
| Q1 25 | 1.33× | 2.50× | ||
| Q4 24 | 3.57× | 3.57× | ||
| Q3 24 | -29.31× | 1.29× | ||
| Q2 24 | 3.85× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AENT
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
